These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response. Lennertz L, Quednow BB, Schuhmacher A, Petrovsky N, Frommann I, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Höfels S, Pukrop R, Klosterkötter J, Franke PE, Wölwer W, Gaebel W, Häfner H, Maier W, Wagner M, Mössner R. Int J Neuropsychopharmacol; 2012 Oct; 15(9):1205-15. PubMed ID: 22078257 [Abstract] [Full Text] [Related]
3. 5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option. Lennertz L, Wagner M, Grabe HJ, Franke PE, Guttenthaler V, Rampacher F, Schulze-Rauschenbach S, Vogeley A, Benninghoff J, Ruhrmann S, Pukrop R, Klosterkötter J, Falkai P, Maier W, Mössner R. Eur Neuropsychopharmacol; 2014 Jan; 24(1):86-94. PubMed ID: 23928294 [Abstract] [Full Text] [Related]
5. Oxytocin receptor gene polymorphisms exert a modulating effect on the onset age in patients with obsessive-compulsive disorder. Kang JI, Kim HW, Kim CH, Hwang EH, Kim SJ. Psychoneuroendocrinology; 2017 Dec; 86():45-52. PubMed ID: 28915380 [Abstract] [Full Text] [Related]
9. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH, Hanna GL. Arch Gen Psychiatry; 2006 Jul; 63(7):778-85. PubMed ID: 16818867 [Abstract] [Full Text] [Related]
11. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder. Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, Baca-García E, Labad J, Fernández-Piqueras J, Real E, Vaquero C, Pérez M, Dolengevich H, González JR, Bayés M, de Cid R, Vallejo J, Estivill X. Biol Psychiatry; 2008 Mar 15; 63(6):619-28. PubMed ID: 17884018 [Abstract] [Full Text] [Related]
12. Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder. Cengiz M, Okutan SN, Bayoglu B, Sakalli Kani A, Bayar R, Kocabasoglu N. Genet Test Mol Biomarkers; 2015 May 15; 19(5):228-34. PubMed ID: 25751280 [Abstract] [Full Text] [Related]
13. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A, Knüpfer H, Meyer PM, Luthardt J, Jahn I, Lobsien D, Heinke W, Brust P, Hegerl U, Sabri O. Int J Neuropsychopharmacol; 2011 Jun 15; 14(5):606-17. PubMed ID: 21232166 [Abstract] [Full Text] [Related]
14. Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder. Dickel DE, Veenstra-VanderWeele J, Bivens NC, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH, Hanna GL. Biol Psychiatry; 2007 Feb 01; 61(3):322-9. PubMed ID: 17241828 [Abstract] [Full Text] [Related]
16. The serotonin-1Dbeta receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa. Levitan RD, Kaplan AS, Masellis M, Basile VS, Richter MA, Kennedy JL. Eur Neuropsychopharmacol; 2006 Jan 30; 16(1):1-6. PubMed ID: 15944142 [Abstract] [Full Text] [Related]
17. Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic. Ruland T, Domschke K, Schütte V, Zavorotnyy M, Kugel H, Notzon S, Vennewald N, Ohrmann P, Arolt V, Pfleiderer B, Zwanzger P. Eur Neuropsychopharmacol; 2015 Oct 30; 25(10):1677-82. PubMed ID: 26235955 [Abstract] [Full Text] [Related]
18. Common variants of HTR3 genes are associated with obsessive-compulsive disorder and its phenotypic expression. Kim HW, Kang JI, Lee SH, An SK, Sohn SY, Hwang EH, Lee SY, Kim SJ. Sci Rep; 2016 Sep 12; 6():32564. PubMed ID: 27616601 [Abstract] [Full Text] [Related]
19. Corrigendum to "gender in obsessive-compulsive disorder: clinical and genetic findings" [Eur. Neuropsychopharmacol. 14 (2004) 105-113]. Lochner C, Hemmings SM, Kinnear CJ, Moolman-Smook JC, Corfield VA, Knowles JA, Niehaus DJ, Stein DJ. Eur Neuropsychopharmacol; 2004 Oct 12; 14(5):437-45. PubMed ID: 15468463 [Abstract] [Full Text] [Related]
20. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder. Lin PY. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):683-9. PubMed ID: 17291658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]